Detection of ATM deletion in chronic lymphocytic leukemia by fluorescence in situ hybridization
10.3760/cma.j.issn.1009-9921.2010.05.014
- VernacularTitle:荧光原位杂交技术在检测慢性淋巴细胞白血病ATM基因缺失中的应用
- Author:
Mingli LI
;
Liping SU
;
Jingping ZHANG
;
Jin ZHAO
;
Jufen XIE
;
Qianru LI
;
Meijing ZHENG
;
Yongan ZHOU
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphocytic,chronic;
In situ hybridization,fluorescence;
Gene deletion
- From:
Journal of Leukemia & Lymphoma
2010;19(5):301-303,312
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate ATM deletion [del (ATM)] in chronic lymphocytic leukemia (CLL) and study its correlation with the clinical stage. Methods Spectrum Orange~(TM) labeled sequence specific DNA probe for ATM locus on 11q22.3 and fluorescence in Situ hybridization (FISH) was used to examine del (ATM) in 28 newly diagnose patients with CLL. FISH analysis were performed on bone marrow smears. Clinical staging was done according to Binet Method.Fisher exact propability was used to study the relations between del (ATM) and clinical feature. Results 4 out of the 28 cases were found with deletion of ATM. The incidence of del (ATM) in BinetA, BinetB and BinetC was 1/9 (11.1 %), 1/8 (12.5 %), 2/11 (18.2 %), respectively. Fisher exact propability showed that deletion of ATM was not associated with its clinical feature. Conclusion Application of FISH on archival bone marrow smears is a simple, liable method, and can be readly used to retrospective study of clonal blood system diseases. Deletion of ATM was common cytogenetic changes in CLL patients.And the significance of del (ATM) in the prognosis of CLL in China needs to be further investigated.
